首页> 外国专利> ONCOLYTIC MODIFIED ADENOVIRUSES, MODIFIED VIRUSES FOR TREATING DISEASE, AND VIRAL FORMULATIONS CONTAINING THESE

ONCOLYTIC MODIFIED ADENOVIRUSES, MODIFIED VIRUSES FOR TREATING DISEASE, AND VIRAL FORMULATIONS CONTAINING THESE

机译:溶瘤修饰的腺病毒,用于治疗疾病的修饰病毒以及包含这些的病毒制剂

摘要

PROBLEM TO BE SOLVED: To provide modified viruses for treating diseases that selectively exert cell-killing activity on diseases associated with cancer cells or the cells accelerating stabilization of ARE-mRNA, such as osteoporosis, rheumatism, viral disease and inflammatory disease.SOLUTION: The invention provides an antitumor adenovirus formulation (described as dl355 in Fig. 1) containing a modified adenovirus with E4orf6 encoding an E4orf6 protein in which C-terminal region is deleted or a modified E4orf6 protein consisting of an amino acid sequence represented by a particular sequence.SELECTED DRAWING: Figure 1
机译:解决的问题:提供修饰的病毒用于治疗疾病,这些疾病可选择性地对与癌细胞或促进ARE-mRNA稳定化的细胞相关的疾病(例如骨质疏松症,风湿病,病毒性疾病和炎性疾病)发挥杀伤活性。本发明提供了一种抗肿瘤腺病毒制剂(在图1中描述为dl355),其含有带有E4orf6的修饰的腺病毒,该E4orf6编码的E4orf6蛋白缺失了C端区域,或者包含由特定序列表示的氨基酸序列组成的E4orf6蛋白。选定的图纸:图1

著录项

  • 公开/公告号JP2016160249A

    专利类型

  • 公开/公告日2016-09-05

    原文格式PDF

  • 申请/专利权人 HOKKAIDO UNIV;

    申请/专利号JP20150043345

  • 发明设计人 TONO FUMIHIRO;

    申请日2015-03-05

  • 分类号A61K35/761;A61P35/00;A61P19/10;A61P29/00;A61P31/12;A61P31/22;A61P31/14;A61P31/16;A61P31/20;A61K31/7088;A61K48/00;C12N7/00;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 14:46:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号